🇺🇸 FDA
Patent

US 6750254

Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same

expired A61PA61P25/00A61P43/00

Quick answer

US patent 6750254 (Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/00, A61P43/00, A61P9/12